↓ Skip to main content

Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia

Overview of attention for article published in Current Hematologic Malignancy Reports, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
1 X user
patent
5 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
70 Mendeley
Title
Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
Published in
Current Hematologic Malignancy Reports, October 2018
DOI 10.1007/s11899-018-0472-8
Pubmed ID
Authors

Daniel G. Guy, Geoffrey L. Uy

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 17%
Researcher 9 13%
Student > Master 8 11%
Student > Doctoral Student 6 9%
Other 6 9%
Other 6 9%
Unknown 23 33%
Readers by discipline Count As %
Medicine and Dentistry 15 21%
Biochemistry, Genetics and Molecular Biology 10 14%
Immunology and Microbiology 10 14%
Engineering 3 4%
Agricultural and Biological Sciences 2 3%
Other 5 7%
Unknown 25 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2024.
All research outputs
#3,525,602
of 24,453,338 outputs
Outputs from Current Hematologic Malignancy Reports
#63
of 442 outputs
Outputs of similar age
#70,536
of 348,489 outputs
Outputs of similar age from Current Hematologic Malignancy Reports
#6
of 18 outputs
Altmetric has tracked 24,453,338 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 442 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,489 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.